S&P 500   4,280.15 (+1.73%)
DOW   33,761.05 (+1.27%)
QQQ   330.39 (+1.95%)
AAPL   172.10 (+2.14%)
MSFT   291.91 (+1.70%)
META   180.50 (+1.70%)
GOOGL   121.68 (+2.39%)
AMZN   143.55 (+2.07%)
TSLA   900.09 (+4.68%)
NVDA   187.09 (+4.27%)
NIO   21.11 (+1.39%)
BABA   94.77 (-0.11%)
AMD   100.83 (+2.76%)
MU   65.04 (+4.36%)
T   18.27 (+1.27%)
CGC   3.30 (+4.76%)
GE   79.93 (+1.31%)
F   16.18 (+2.21%)
DIS   121.57 (+3.30%)
AMC   24.44 (-3.97%)
PYPL   101.10 (+2.01%)
PFE   50.11 (+3.77%)
NFLX   249.30 (+2.72%)
S&P 500   4,280.15 (+1.73%)
DOW   33,761.05 (+1.27%)
QQQ   330.39 (+1.95%)
AAPL   172.10 (+2.14%)
MSFT   291.91 (+1.70%)
META   180.50 (+1.70%)
GOOGL   121.68 (+2.39%)
AMZN   143.55 (+2.07%)
TSLA   900.09 (+4.68%)
NVDA   187.09 (+4.27%)
NIO   21.11 (+1.39%)
BABA   94.77 (-0.11%)
AMD   100.83 (+2.76%)
MU   65.04 (+4.36%)
T   18.27 (+1.27%)
CGC   3.30 (+4.76%)
GE   79.93 (+1.31%)
F   16.18 (+2.21%)
DIS   121.57 (+3.30%)
AMC   24.44 (-3.97%)
PYPL   101.10 (+2.01%)
PFE   50.11 (+3.77%)
NFLX   249.30 (+2.72%)
S&P 500   4,280.15 (+1.73%)
DOW   33,761.05 (+1.27%)
QQQ   330.39 (+1.95%)
AAPL   172.10 (+2.14%)
MSFT   291.91 (+1.70%)
META   180.50 (+1.70%)
GOOGL   121.68 (+2.39%)
AMZN   143.55 (+2.07%)
TSLA   900.09 (+4.68%)
NVDA   187.09 (+4.27%)
NIO   21.11 (+1.39%)
BABA   94.77 (-0.11%)
AMD   100.83 (+2.76%)
MU   65.04 (+4.36%)
T   18.27 (+1.27%)
CGC   3.30 (+4.76%)
GE   79.93 (+1.31%)
F   16.18 (+2.21%)
DIS   121.57 (+3.30%)
AMC   24.44 (-3.97%)
PYPL   101.10 (+2.01%)
PFE   50.11 (+3.77%)
NFLX   249.30 (+2.72%)
S&P 500   4,280.15 (+1.73%)
DOW   33,761.05 (+1.27%)
QQQ   330.39 (+1.95%)
AAPL   172.10 (+2.14%)
MSFT   291.91 (+1.70%)
META   180.50 (+1.70%)
GOOGL   121.68 (+2.39%)
AMZN   143.55 (+2.07%)
TSLA   900.09 (+4.68%)
NVDA   187.09 (+4.27%)
NIO   21.11 (+1.39%)
BABA   94.77 (-0.11%)
AMD   100.83 (+2.76%)
MU   65.04 (+4.36%)
T   18.27 (+1.27%)
CGC   3.30 (+4.76%)
GE   79.93 (+1.31%)
F   16.18 (+2.21%)
DIS   121.57 (+3.30%)
AMC   24.44 (-3.97%)
PYPL   101.10 (+2.01%)
PFE   50.11 (+3.77%)
NFLX   249.30 (+2.72%)
NYSE:BXC

BlueLinx - BXC Stock Forecast, Price & News

$77.87
+1.06 (+1.38%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$76.55
$78.47
50-Day Range
$61.94
$90.60
52-Week Range
$45.86
$100.01
Volume
102,970 shs
Average Volume
166,812 shs
Market Capitalization
$752.07 million
P/E Ratio
2.38
Dividend Yield
N/A
Price Target
$104.75

BlueLinx MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
34.5% Upside
$104.75 Price Target
Short Interest
Healthy
4.97% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.17mentions of BlueLinx in the last 14 days
Based on 10 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
-29.27%
From $26.68 to $18.87 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.14 out of 5 stars

Construction Sector

57th out of 105 stocks

Lumber, Plywood, & Millwork Industry

1st out of 1 stocks

BXC stock logo

About BlueLinx (NYSE:BXC) Stock

BlueLinx Holdings Inc., together with its subsidiaries, distributes residential and commercial building products in the United States. The company distributes specialty products comprising engineered wood, industrial products, cedar, moulding, siding, metal, and insulation products; and structural products include lumber, plywood, oriented strand boards, rebars and remesh, spruce, and other wood products primarily that are used for structural support in construction projects. It also provides various value-added services and solutions to customers and suppliers. The company serves dealers, specialty distributors, national home centers, and manufactured housing customers through a network of distribution centers. BlueLinx Holdings Inc. was incorporated in 2004 and is headquartered in Marietta, Georgia.

BlueLinx Price Performance

NYSE:BXC traded up $1.06 during mid-day trading on Friday, hitting $77.87. 102,970 shares of the stock traded hands, compared to its average volume of 166,812. The business's 50-day moving average price is $73.64 and its 200 day moving average price is $77.43. The company has a quick ratio of 1.84, a current ratio of 3.73 and a debt-to-equity ratio of 1.11. The company has a market cap of $752.07 million, a PE ratio of 2.38 and a beta of 1.84. BlueLinx has a 12-month low of $45.86 and a 12-month high of $100.01.

BlueLinx (NYSE:BXC - Get Rating) last announced its earnings results on Tuesday, August 2nd. The construction company reported $7.48 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.64 by ($0.16). BlueLinx had a net margin of 7.26% and a return on equity of 79.52%. During the same quarter in the prior year, the business earned $11.61 EPS. On average, analysts expect that BlueLinx will post 26.68 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the company. TheStreet raised BlueLinx from a "c" rating to a "b-" rating in a research report on Wednesday, May 4th. Benchmark dropped their price objective on shares of BlueLinx to $115.00 in a report on Tuesday. StockNews.com upgraded shares of BlueLinx from a "hold" rating to a "buy" rating in a research note on Friday, August 5th. Seaport Res Ptn restated a "buy" rating on shares of BlueLinx in a research note on Monday, July 25th. Finally, Craig Hallum reduced their price objective on shares of BlueLinx from $138.00 to $127.00 in a research note on Thursday, August 4th. Six investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and an average target price of $104.75.

Receive BXC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BlueLinx and its competitors with MarketBeat's FREE daily newsletter.

BXC Stock News Headlines

Benchmark Lowers BlueLinx (NYSE:BXC) Price Target to $115.00
BlueLinx (NYSE:BXC) Price Target Cut to $115.00
BlueLinx (NYSE:BXC) Upgraded at StockNews.com
Craig Hallum Lowers BlueLinx (NYSE:BXC) Price Target to $127.00
BlueLinx (NYSE:BXC) Shares Gap Down Following Weak Earnings
BlueLinx (NYSE:BXC) Shares Gap Up to $80.00
BlueLinx Announces Second Quarter 2022 Results
BlueLinx (BXC) Set to Announce Quarterly Earnings on Tuesday
See More Headlines
Receive BXC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BlueLinx and its competitors with MarketBeat's FREE daily newsletter.

BXC Company Calendar

Last Earnings
8/02/2022
Today
8/12/2022
Next Earnings (Estimated)
11/01/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Lumber, plywood, & millwork
Sub-Industry
Trading Companies & Distributors
CUSIP
09624H10
Employees
2,055
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$104.75
High Stock Price Forecast
$127.00
Low Stock Price Forecast
$75.00
Forecasted Upside/Downside
+34.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$296.13 million
Pretax Margin
9.70%

Debt

Sales & Book Value

Annual Sales
$4.28 billion
Cash Flow
$34.00 per share
Book Value
$51.74 per share

Miscellaneous

Free Float
9,214,000
Market Cap
$752.07 million
Optionable
Optionable
Beta
1.84

Key Executives














BXC Stock - Frequently Asked Questions

Should I buy or sell BlueLinx stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for BlueLinx in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" BXC shares.
View BXC analyst ratings
or view top-rated stocks.

What is BlueLinx's stock price forecast for 2022?

5 Wall Street research analysts have issued 1-year price objectives for BlueLinx's stock. Their BXC share price forecasts range from $75.00 to $127.00. On average, they predict the company's share price to reach $104.75 in the next year. This suggests a possible upside of 34.8% from the stock's current price.
View analysts price targets for BXC
or view top-rated stocks among Wall Street analysts.

How have BXC shares performed in 2022?

BlueLinx's stock was trading at $95.76 at the beginning of the year. Since then, BXC stock has decreased by 18.8% and is now trading at $77.72.
View the best growth stocks for 2022 here
.

Are investors shorting BlueLinx?

BlueLinx saw a increase in short interest in the month of July. As of July 31st, there was short interest totaling 446,100 shares, an increase of 10.4% from the July 15th total of 403,900 shares. Based on an average daily trading volume, of 180,300 shares, the days-to-cover ratio is presently 2.5 days. Approximately 5.0% of the company's shares are short sold.
View BlueLinx's Short Interest
.

When is BlueLinx's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 1st 2022.
View our BXC earnings forecast
.

How were BlueLinx's earnings last quarter?

BlueLinx Holdings Inc. (NYSE:BXC) released its quarterly earnings results on Tuesday, August, 2nd. The construction company reported $7.48 earnings per share for the quarter, missing the consensus estimate of $7.64 by $0.16. BlueLinx had a trailing twelve-month return on equity of 79.52% and a net margin of 7.26%. During the same quarter in the previous year, the company posted $11.61 earnings per share.

What is Mitch Lewis' approval rating as BlueLinx's CEO?

56 employees have rated BlueLinx Chief Executive Officer Mitch Lewis on Glassdoor.com. Mitch Lewis has an approval rating of 49% among the company's employees. This puts Mitch Lewis in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of BlueLinx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BlueLinx investors own include Novavax (NVAX), Micron Technology (MU), Co-Diagnostics (CODX), Livongo Health (LVGO), Intel (INTC), Maxar Technologies (MAXR), Civeo (CVEO), Nautilus (NLS), Sorrento Therapeutics (SRNE) and Hologic (HOLX).

What is BlueLinx's stock symbol?

BlueLinx trades on the New York Stock Exchange (NYSE) under the ticker symbol "BXC."

Who are BlueLinx's major shareholders?

BlueLinx's stock is owned by many different retail and institutional investors. Top institutional investors include JPMorgan Chase & Co. (1.66%), Rock Creek Group LP (1.29%), Royce & Associates LP (1.27%), Deutsche Bank AG (0.81%), Artemis Investment Management LLP (0.77%) and SG Americas Securities LLC (0.73%). Insiders that own company stock include Alexander S Averitt, Brian J Sasadu, Carol B Yancey, Kelly Janzen, Kim S Fennebresque, Mitchell B Lewis, Mitchell B Lewis, Nokomis Capital, LLC, Shyam K Reddy and Shyam K Reddy.
View institutional ownership trends
.

How do I buy shares of BlueLinx?

Shares of BXC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BlueLinx's stock price today?

One share of BXC stock can currently be purchased for approximately $77.72.

How much money does BlueLinx make?

BlueLinx (NYSE:BXC) has a market capitalization of $750.78 million and generates $4.28 billion in revenue each year. The construction company earns $296.13 million in net income (profit) each year or $32.71 on an earnings per share basis.

How many employees does BlueLinx have?

The company employs 2,055 workers across the globe.

How can I contact BlueLinx?

BlueLinx's mailing address is 1950 SPECTRUM CIRCLE SUITE 300, MARIETTA GA, 30067. The official website for the company is www.bluelinxco.com. The construction company can be reached via phone at (770) 953-7000, via email at ir@audentestx.com, or via fax at 770-221-8902.

This page (NYSE:BXC) was last updated on 8/12/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.